Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses
Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-11-01
Data overview
- Formats
- HTML
- File languages
- English, French